• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Request for Applications: Kidney Cancer Career Development Award

Kidney Cancer Career Development Award

Dana-Farber/Harvard Cancer Center Kidney Cancer Program

DUE DATE: 09/15/09

The Kidney Cancer Program of the Dana-Farber/Harvard Cancer Center, under the leadership of Dr. Michael B. Atkins, seeks applications for The Career Development Award in Kidney Cancer Research. Funding will be provided through the Specialized Program of Research Excellence (SPORE) mechanism, a National Cancer Institute sponsored program and industry support. Eligible candidates are those who are in their final year of clinical fellowship or postdoctoral fellowship (MD, PhD or MD/PhD required) or within their first 3 years on staff. A prior track record in kidney cancer research is preferred but not required. The awardee will receive up to two years of funding not to exceed $40,000 DIR per year (exclusive of F&A), which can be used for salary and/or support of research at Harvard Medical School, the Harvard School of Public Health or any of the Harvard-affiliated hospitals. Funding sources include NIH award, and sundry monies. Depending on the source of funding for each award, awarded F&A will vary from 15% to your DHHS institutional negotiated rate. Therefore, we ask that F&A NOT be included in the requested budget and that applications must have institutional sign-off. Funding provided needs to be spent within the budgeted time period. Proposals should present a two year research plan with clearly defined milestones. Applicants will be evaluated using the 5 point NIH scale according to the following criteria: 

1. The scientific merit/quality of the proposal (coherent presentation, candidate's own work, kidney cancer focus, translational nature)

2. The quality of the candidate (quality of previous work; potential for academic career in kidney cancer)

3. The quality of the research environment (mentor support and track record, resources available) Consideration will also be given to investigators expressing interest in shifting their research focus to kidney cancer. 

In this instance, items that will also be considered include: 

1.  The seriousness of the commitment to translational research in kidney cancer

2.  The willingness of the individual to continue a productive relationship with the SPORE and the Kidney Cancer Program. The awardee will be expected to become a member of the DF/HCC Kidney Cancer Program and participate in Program activities including monthly research conferences, thrice yearly half-day seminars, and the annual retreat. Women and minority candidates are encouraged to apply. 

Applications should be sent electronically to the Program Administrator, Aline D. Nandelstadt at anandels@bidmc.harvard.edu no later than 4 pm on 09/15/09. Minority and women applicants are strongly encouraged to apply.  Applications must contain the following components:

  • Abstract of proposed research
  • Abbreviated Research Plan including the Specific Aims, Background and Significance, Preliminary Data, and Experimental Methods, not to exceed 5 pages, exclusive of the proposed milestones and literature cited.
  • Applicants Career Goals (1 page)  
  • Research and Environment for proposed research
  • Mentor(s) Letter of Support
  • Applicant’s NIH Biosketch
  • Mentor’s Biosketch
  • Applicant’s NIH Other Support Page
  • Proposed Budget; must not exceed $60,000/year (Inclusive of indirect costs) x 2 years
  • Cover letter with institutional signature
  • IRB approval documents (if applicable)
  • Human Subject Training Certificate (if applicable)

Anticipated Award Dates:  10/01/09 – 09/30/10